Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

AIM: The aim of the present study was to analyse concomitant drug use and its association with outcome in patients (N = 17 701) receiving rivaroxaban or standard of care (SOC) for the prevention of venous thromboembolism after major orthopaedic surgery in the non‐interventional, phase IV XAMOS (Xare...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreutz, Reinhold, Haas, Sylvia, Holberg, Gerlind, Lassen, Michael R., Mantovani, Lorenzo G., Schmidt, André, Turpie, Alexander G. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Drug Interactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799939/
https://www.ncbi.nlm.nih.gov/pubmed/26580706
http://dx.doi.org/10.1111/bcp.12836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799939/
https://www.ncbi.nlm.nih.gov/pubmed/26580706
http://dx.doi.org/10.1111/bcp.12836

Ejemplares similares